Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
ENZ

ENZ - Enzo Biochem Inc Stock Price, Fair Value and News

$0.54 
Market Closed

ENZ Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ENZ Price Action

ENZ RSI Chart

ENZ Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ENZ Valuation

ENZ Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

ENZ Fundamentals

ENZ Revenue

ENZ Earnings

ENZ Profitability

ENZ Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202529.1M27.5M00
202432.8M33.3M31.9M30.3M
202331.9M31.5M31.1M31.8M
2022118.2M111.6M32.6M32.2M
202196.6M112.4M117.7M115.6M
202078.6M77.3M76.0M84.5M
201988.6M83.0M81.2M79.9M
2018103.1M102.1M101.0M95.4M
2017105.6M106.2M105.2M104.1M
201699.4M101.9M102.8M103.9M
201596.8M96.8M97.6M98.0M
201492.9M94.3M95.9M96.6M
2013100.2M96.8M93.7M92.2M
2012103.4M103.5M103.1M103.0M
201199.6M100.8M102.0M102.1M
201000098.3M
Get all data in R, Python etc through our Historical Stock Data APIs

About Enzo Biochem Inc

ENZ
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also provides its products to scientific experts in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment provides molecular and other clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. It operates a full-service clinical laboratory in Farmingdale, New York; a network of 30 patient service centers in New York and New Jersey; and a free-standing ‘STAT' or rapid response laboratories in New York City and Connecticut, as well as a full-service phlebotomy center and an in-house logistics department. The Therapeutics segment develops novel approaches in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. It markets its products and services through its direct sales force and a network of distributors in the United States and internationally. The company was founded in 1976 and is headquartered in Farmingdale, New York.
 CEO
 WEBSITEenzo.com
 SECTORHealthcare
 INDUSTRYDiagnostics & Research
 EMPLOYEES465